Equity ETFs Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO By Max ChenSeptember 23, 2016
Equity ETFs M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound By Max ChenSeptember 12, 2016
Featured M&A Activity Will Support Pharma ETFs Through Rising Rate Environment By Tom LydonJuly 9, 2015